Skip to main content
Year archive

ANAGENICS LIMITED — 2016 filings

All 62 regulatory filings released by ANAGENICS LIMITED (AN1) in 2016, sourced directly from the official regulator.

62 Filings
2016 Period
2016 filings (62)
Filing Released Lang
Cellmid Updates on CxBladder License 2 pages 89.0KB
Regulatory Filings
2016-12-11 English
Cellmid receives 831K R&D tax credit 1 page 79.3KB
Regulatory Filings
2016-11-28 English
AGM Presentation by CEO 28 pages 2.1MB
Regulatory Filings
2016-11-20 English
Results of Annual General Meeting 2 pages 62.9KB
Regulatory Filings
2016-11-20 English
Change of Director's Interest Notice - Halasz 3 pages 113.3KB
Regulatory Filings
2016-11-16 English
Cleansing Statement & Appendix 3B 11 pages 262.0KB
Regulatory Filings
2016-11-08 English
USA launch of evolis 2 pages 87.8KB
Regulatory Filings
2016-11-02 English
Cleansing Statement and Appendix 3B 11 pages 288.6KB
Regulatory Filings
2016-11-01 English
Cellmid Capital Raising 2 pages 86.5KB
Regulatory Filings
2016-10-31 English
ASX Market Release - Reinstatement 1 page 84.9KB
Regulatory Filings
2016-10-31 English
Change of Director's Interest Notice - Halasz 3 pages 113.0KB
Regulatory Filings
2016-10-31 English
Appendix 4C - quarterly 7 pages 190.1KB
Regulatory Filings
2016-10-30 English
Suspension from Official Quotation 2 pages 223.4KB
Regulatory Filings
2016-10-27 English
Appendix 3B 9 pages 470.0KB
Regulatory Filings
2016-10-27 English
Ceasing to be a substantial holder 1 page 72.0KB
Regulatory Filings
2016-10-26 English
Trading Halt 2 pages 228.6KB
Regulatory Filings
2016-10-25 English
Exercise of Options (CDYO) 1 page 31.3KB
Regulatory Filings
2016-10-24 English
Appendix 3B 8 pages 396.4KB
Regulatory Filings
2016-10-20 English
Notice of Annual General Meeting/Proxy Form 9 pages 288.2KB
Regulatory Filings
2016-10-18 English
Change of Director's Interest Notice - Gordon 2 pages 120.1KB
Regulatory Filings
2016-10-16 English
Change of Director's Interest Notice - Walton 2 pages 119.0KB
Regulatory Filings
2016-10-16 English
Change of Director's Interest Notice - Halasz 3 pages 115.8KB
Regulatory Filings
2016-10-16 English
Change of Director's Interest Notice - King 3 pages 121.3KB
Regulatory Filings
2016-10-16 English
CELLMID RECORDS HIGHEST EVER QUARTERLY SALES FOR EVOLIS 2 pages 104.5KB
Regulatory Filings
2016-10-09 English
Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer 3 pages 116.0KB
Regulatory Filings
2016-10-04 English
Cellmid 2016 Annual Report to Shareholders 74 pages 3.9MB
Regulatory Filings
2016-09-28 English
Quotation of Listed Options (CDYO) 1 page 92.1KB
Regulatory Filings
2016-09-27 English
Expiry Of Listed Options (CDYO) 3 pages 257.8KB
Regulatory Filings
2016-09-22 English
European Midkine Patent For Surgical Adhesion Allowed 2 pages 81.7KB
Regulatory Filings
2016-09-21 English
Change of Director's Interest Notice 3 pages 140.6KB
Regulatory Filings
2016-09-18 English
Date of Annual General Meeting 1 page 85.9KB
Regulatory Filings
2016-09-12 English
Appendix 4G and Corporate Governance Statement 26 pages 659.3KB
Regulatory Filings
2016-08-30 English
Appendix 4E and Preliminary Final Report 59 pages 742.6KB
Regulatory Filings
2016-08-29 English
New Publication for Cellmid's Midkine Antibody 3 pages 122.2KB
Regulatory Filings
2016-08-08 English
Cellmid Investor Presentation 20 pages 2.4MB
Regulatory Filings
2016-08-02 English
Transcript of Cellmid Investor Briefing Call 2 pages 67.6KB
Regulatory Filings
2016-07-28 English
Appendix 4C - quarterly 6 pages 186.3KB
Regulatory Filings
2016-07-25 English
Ikon Legal Action 2 pages 64.8KB
Regulatory Filings
2016-07-21 English
Cellmid Investor Briefing 2 pages 111.8KB
Regulatory Filings
2016-07-20 English
USA Distribution Partnership for Cellmid's Evolis 2 pages 122.5KB
Regulatory Filings
2016-07-19 English
Change in substantial holding 4 pages 127.3KB
Regulatory Filings
2016-07-17 English
Change in substantial holding 3 pages 168.0KB
Regulatory Filings
2016-07-04 English
Change in substantial holding 3 pages 138.6KB
Regulatory Filings
2016-07-03 English
Change in substantial holding 3 pages 117.5KB
Regulatory Filings
2016-06-29 English
MIDKINE INTERVIEWS WITH PHARMATELEVISION PUBLISHED 3 pages 172.9KB
Regulatory Filings
2016-06-28 English
Change in substantial holding 3 pages 135.4KB
Regulatory Filings
2016-06-28 English
Becoming a substantial holder 3 pages 142.0KB
Regulatory Filings
2016-06-27 English
MK antibody publication and patent in bone healing 3 pages 110.0KB
Regulatory Filings
2016-06-23 English
Change of Director's Interest Notice - Halasz 3 pages 138.0KB
Regulatory Filings
2016-06-19 English
CELLMID LAUNCHES EVOLIS PROFESSIONAL PRODUCTS 1 pag
Regulatory Filings
2016-06-13 English
Update on Japanese Sales 1 page 86.7KB
Regulatory Filings
2016-05-25 English
4th MIDKINE SYMPOSIUM RESULTS 2 pages 109.9KB
Regulatory Filings
2016-05-10 English
Significant Scientific Appointment for Advisory Board Chair 3 pages 184.7KB
Regulatory Filings
2016-05-08 English
Appendix 4C - quarterly 6 pages 183.9KB
Regulatory Filings
2016-04-20 English
Midkine Strategy Update 2 pages 81.3KB
Regulatory Filings
2016-04-07 English
Fourth Midkine Symposium to be held in Budapest 2 pages 95.2KB
Regulatory Filings
2016-04-03 English
Transcript of Cellmid Investor Briefing 2 pages 95.5KB
Regulatory Filings
2016-02-28 English
Cellmid to Refinance RnD Loan 2 pages 82.0KB
Regulatory Filings
2016-02-25 English
Appendix 4D and Half Year Accounts 25 pages 1.7MB
Regulatory Filings
2016-02-24 English
Cellmid Investor Briefing 2 pages 98.6KB
Regulatory Filings
2016-02-22 English
Director Appointment/Resignation 2 pages 53.8KB
Regulatory Filings
2016-02-03 English
Appendix 4C - quarterly 8 pages 150.2KB
Regulatory Filings
2016-01-26 English